Accordingly, extrapolating our mouse findings to humans suggests that early loss of p53 through a p53−/− genetic mutation in cells infected by HTLV-1 foretells a worse prognosis compared to a corresponding infection in a counterpart p53+/+ setting. Here, TP53 is linked to infection.